Strong Recommendations Supported Only by Low-Certainty Evidence, Pharmaceutical Company Payments, and Accuracy of Conflict-of-Interest Disclosure in Japanese Clinical Practice Guidelines for Seven Major Cancers.

IF 4.7 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Journal of Evidence‐Based Medicine Pub Date : 2026-09-27 DOI:10.1111/jebm.70201

Hayase Hakariya, Akemi Hara, Janne Estill, Yangqin Xun, Long Ge, Yaolong Chen, Hiroaki Saito, Tetsuya Tanimoto, Hiroaki Shimmura, Akihiko Ozaki

引用次数: 0

查看原文本刊更多论文

日本七种主要癌症临床实践指南中仅由低确定性证据、制药公司付款和利益冲突披露准确性支持的强烈建议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Evidence‐Based Medicine MEDICINE, GENERAL & INTERNAL-

CiteScore

11.20

自引率

1.40%

发文量

期刊介绍： The Journal of Evidence-Based Medicine (EMB) is an esteemed international healthcare and medical decision-making journal, dedicated to publishing groundbreaking research outcomes in evidence-based decision-making, research, practice, and education. Serving as the official English-language journal of the Cochrane China Centre and West China Hospital of Sichuan University, we eagerly welcome editorials, commentaries, and systematic reviews encompassing various topics such as clinical trials, policy, drug and patient safety, education, and knowledge translation.